Riskpilot← Back to searchSign inGet full accessBARENTZYMES AS
ASActiveOrg 912851478Haraldsgata 90, 3. Etasje, 5528 HaugesundResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20130 employees
Revenue 2024
NOK 0
EBITDA margin
—
+4% vs 2023
Equity ratio
99.7%
Financial strength
Net profit 2024
NOK -201K
+6% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -218K | +4% |
| Net profit | NOK -201K | +6% |
| Total assets | NOK 15,1M | +1680% |
| Equity | NOK 15M | +1693% |
| Employees | 0 | — |
Legal name
BARENTZYMES AS
Org number
912851478
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
7. desember 2013
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Geir utne berg
Company purpose
Å drive forretningsvirksomhet med oppdagelse, registrering, utvikling, forskning og salg av enzymer og produkter og tjenester knyttet til bruk av enzymer. Herunder skal selskapet også kunne investere i andre selskaper innenfor samme forretningsområde.
Address
Haraldsgata 90, 3. Etasje, 5528 Haugesund
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 5 766 | 3 290 | 1 367 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −453 | −4 439 | −3 144 | 26 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −511 | −6 662 | −9 413 | −2 879 | −127 | −1 355 | −964 | −1 626 | −295 | −1 014 | −228 | −218 |
| Depreciation & amort. | −0 | −0 | −84 | −86 | −86 | −86 | −87 | −2 | −0 | −0 | −0 | −0 |
| EBIT | −511 | −6 662 | −9 497 | −2 966 | −213 | −1 441 | −1 051 | −1 629 | −295 | −1 014 | −228 | −218 |
| Net financials | 1 | −184 | −48 | −23 | 247 | 29 | −70 | −12 | 0 | 25 | 14 | 17 |
| Profit before tax | −510 | −6 846 | −9 545 | −2 988 | 33 | −1 412 | −1 122 | −1 640 | −295 | −989 | −215 | −201 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −510 | −6 846 | −9 545 | −2 988 | 33 | −1 412 | −1 122 | −1 640 | −295 | −989 | −215 | −201 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 927 | 7 309 | 7 689 | 3 161 | 2 859 | 11 314 | 3 403 | 1 453 | 2 234 | 1 325 | 848 | 15 097 |
| Equity | 490 | −6 361 | −3 806 | −6 795 | −6 761 | 100 | 978 | 338 | 2 043 | 1 054 | 839 | 15 047 |
| Long-term debt | 0 | 12 059 | 8 959 | 9 609 | 9 609 | 9 609 | 1 408 | 637 | 0 | 0 | 0 | 0 |
| Short-term debt | 437 | 1 612 | 2 537 | 347 | 11 | 1 605 | 1 016 | 478 | 52 | 272 | 9 | 50 |
| Total debt | 437 | 13 671 | 11 496 | 9 955 | 9 620 | 11 214 | 2 424 | 1 115 | 191 | 272 | 9 | 50 |
EBITDA margin
-21815300.0%
This company
15.8%
Market median
-138071619% vs market
20132024
Equity ratio
99.7%
This company
38.2%
Market median
+161% vs market
20132024
Return on equity
-1.3%
This company
18.4%
Market median
-107% vs market
20132024
Net profit margin
-20120000.0%
This company
8.1%
Market median
-248395162% vs market
20132024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20132024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20132024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2016 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Bifrost Og Draupne As | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Sera As
BARENTZYMES AS Board members of BARENTZYMES AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sigurd Steen Aase | Chairman | 0 companies |